All In MedTech

FDA Clearance Tracker · P070008-S001

STRATOS LV/LV-T

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 4, 2008 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 4, 2008

Approved

Time to decision

173 days

Received May 15, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P070008-S001
Device name
STRATOS LV/LV-T
Applicant location
Lake Oswego, OR
Received
May 15, 2008
Decided
Nov 4, 2008
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P070008

Device type

Device class
Class III

Every decision under product code NKE

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ADDITION OF MODELS 500/540 TO THE LUMAX FAMILY OF ICD/CRT-DSAND ICS 3000 PROGRAMMER. THESE MODELS WOULD CONTAIN:¿ A THIRD PROGRAMMABLE CARDIOVERSION / DEFIBRILLATION SHOCK PATHWAY TO OFFER MOREPROGRAMMING OPTIONS¿ AUTOMATIC THRESHOLD MEASUREMENT (ATM) FEATURE ¿ ELECTRONIC MODULE (HARDWARE) UPDATES TO SUPPORT THE THIRD PROGRAMMABLE SHOCK PATH¿ MODIFICATIONS TO THE LITRONIK BATTERIES TO INCREASE CAPACITY¿ NEW STANDARD VALUE OF THE PROGRAMMABLE PACING PULSE WIDTH¿ UPDATED RAM FIRMWARE TO SUPPORT NEW FEATURES

Source documents

Other decisions for Biotronik, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.